Patient Involvement in the Health Technology Assessment Process in Taiwan

por Chen, Kuei An, Huang, Li Ying, Gau, Churn Shiouh
Publicado 2022

The impact of the rare disease and Orphan Drug Act in Taiwan

por Hsiang, Ning-Chun, Huang, Weng-Foung, Gau, Churn-Shiouh, Tsai, Teng-Wen, Chang, Lin-Chau
Publicado 2021

Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome

por Chen, Shih-Chin, Hsiao, Fei-Yuan, Lee, Chii-Ming, Hsu, William Wei-Yuan, Gau, Churn-Shiouh
Publicado 2014

Regulatory considerations for generic products of non-biological complex drugs

por Liu, Yu-Hsuan, Chen, Yi-Shuo, Tseng, Ting, Jiang, Min-Lin, Gau, Churn-Shiouh, Chang, Lin-Chau
Publicado 2023

Epidemiology, clinical profile and treatment patterns of venous thromboembolism in cancer patients in Taiwan: a population-based study

por Chew, Tan-Wei, Gau, Churn-Shiouh, Wen, Yu-Wen, Shen, Li-Jiuan, Mullins, C Daniel, Hsiao, Fei-Yuan
Publicado 2015

Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues

por Chu, Gong-Yau, Chen, Yu-Fu, Chen, Hsiao-Yun, Chan, Ming-Hsiao, Gau, Churn-Shiouh, Weng, Shih-Ming
Publicado 2017

Valuation of the EQ-5D-5L in Taiwan

por Lin, Hsiang-Wen, Li, Chia-Ing, Lin, Fang- Ju, Chang, Jen-Yu, Gau, Churn-Shiouh, Luo, Nan, Pickard, A. Simon, Ramos Goñi, Juan M., Tang, Chao-Hsiun, Hsu, Chien-Ning
Publicado 2018